The Editor-in-Chief will strategically develop journals within the health sciences portfolio focusing on the intersection of diabetes and cancer research.
Base: 34,700 GBP to 49,767 GBP; Bonus/Equity: Not specified; Benefits: Comprehensive benefits package including meeting-free Fridays
Must-have
Nice-to-have
Not specified